Heidi Cuthbert

Supernus (NASDAQ:SUPN) announced FDA recognition of seven years of orphan-drug exclusivity for ONAPGO, its treatment for motor fluctuations in advanced Parkinson's disease.

Gentherm (NASDAQ:THRM) reported third-quarter 2026 product revenue of $405.1 million, up 4.7%, while recording a net loss of $2.6 million.

Forrestania Resources (ASX:FRS) signed a binding agreement with Star Minerals (ASX:SMS) to purchase and process up to 400,000 tonnes of gold-bearing ore from the Tumblegum Project.

Babylon Labs has partnered with HODL1 to help Japanese companies use native Bitcoin as collateral for onchain financial services.

Viva Energy (ASX:VEA) delivered a sharp increase in refining margins for the third quarter of 2026 as recovery efforts continued at its Geelong refinery.

Solana (SOL) activated its Alpenglow consensus upgrade on mainnet-beta on 21 October, introducing a new system for confirming transactions.

Brambles (ASX:BXB) reaffirmed its full-year guidance for sales revenue growth of 2% to 4% and underlying profit growth of 2% to 6%.

Mirvac Group (ASX:MGR) reaffirmed its full-year guidance and reported a 97% investment portfolio occupancy rate in its first-quarter operational update.

Analog Devices (NASDAQ:ADI) has recommended that shareholders reject an unsolicited tender offer from Tutanota to purchase up to 100,000 shares at $525 each.

Natuzzi (NYSE:NTZ) reported second-quarter 2026 net sales of €60 million, down 23.4% year over year, reflecting persistent weakness in furniture demand.